William D. Waddill, Director at Protagonist Therapeutics, Inc (PTGX), sold 25,950 shares at $31.34 ($813K) on 2024-03-01, disclosed to the SEC on 2024-03-01.
Scheduled sale ($813k) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $31.34 | 12,975 | $407K | 50.0% |
| 2 | $31.34 | 12,975 | $407K | 50.0% |
| Total | $31.34 avg | 25,950 | $813K | 100% |
| Filing → |
| PTGX | SELL | 2026-06-01 | $897K | — | Filing → |
| PTGX | SELL | 2026-02-06 | $1.7M | — | Filing → |
| ARWR | SELL | 2025-12-23 | $1.1M | — | Filing → |